Human Gene DDIT4 (ENST00000307365.3) from GENCODE V47lift37
  Description: Regulates cell growth, proliferation and survival via inhibition of the activity of the mammalian target of rapamycin complex 1 (mTORC1). Inhibition of mTORC1 is mediated by a pathway that involves DDIT4/REDD1, AKT1, the TSC1-TSC2 complex and the GTPase RHEB. Plays an important role in responses to cellular energy levels and cellular stress, including responses to hypoxia and DNA damage. Regulates p53/TP53-mediated apoptosis in response to DNA damage via its effect on mTORC1 activity. Its role in the response to hypoxia depends on the cell type; it mediates mTORC1 inhibition in fibroblasts and thymocytes, but not in hepatocytes (By similarity). Required for mTORC1-mediated defense against viral protein synthesis and virus replication (By similarity). Inhibits neuronal differentiation and neurite outgrowth mediated by NGF via its effect on mTORC1 activity. Required for normal neuron migration during embryonic brain development. Plays a role in neuronal cell death. (from UniProt Q9NX09)
Gencode Transcript: ENST00000307365.3
Gencode Gene: ENSG00000168209.4
Transcript (Including UTRs)
   Position: hg19 chr10:74,033,678-74,035,794 Size: 2,117 Total Exon Count: 3 Strand: +
Coding Region
   Position: hg19 chr10:74,033,975-74,034,946 Size: 972 Coding Exon Count: 2 

Page IndexSequence and LinksUniProtKB CommentsPrimersCTDGene Alleles
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr10:74,033,678-74,035,794)mRNA (may differ from genome)Protein (232 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMGIOMIMPubMedReactomeUniProtKB
WikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: DDIT4_HUMAN
DESCRIPTION: RecName: Full=DNA damage-inducible transcript 4 protein; AltName: Full=HIF-1 responsive protein RTP801; AltName: Full=Protein regulated in development and DNA damage response 1; Short=REDD-1;
FUNCTION: Regulates cell growth, proliferation and survival via inhibition of the activity of the mammalian target of rapamycin complex 1 (mTORC1). Inhibition of mTORC1 is mediated by a pathway that involves DDIT4/REDD1, AKT1, the TSC1-TSC2 complex and the GTPase RHEB. Plays an important role in responses to cellular energy levels and cellular stress, including responses to hypoxia and DNA damage. Regulates p53/TP53-mediated apoptosis in response to DNA damage via its effect on mTORC1 activity. Its role in the response to hypoxia depends on the cell type; it mediates mTORC1 inhibition in fibroblasts and thymocytes, but not in hepatocytes (By similarity).Required for mTORC1-mediated defense against viral protein synthesis and virus replication (By similarity). Inhibits neuronal differentiation and neurite outgrowth mediated by NGF via its effect on mTORC1 activity. Required for normal neuron migration during embryonic brain development. Plays a role in neuronal cell death.
SUBUNIT: Monomer. Interacts with BTRC. Identified in a complex with CUL4A, DDB1 and BTRC. Interacts with TXNIP; this inhibits the proteasomal degradation of DDIT4.
SUBCELLULAR LOCATION: Mitochondrion (By similarity). Cytoplasm, cytosol.
TISSUE SPECIFICITY: Broadly expressed, with lowest levels in brain, skeletal muscle and intestine. Up-regulated in substantia nigra neurons from Parkinson disease patients (at protein level).
INDUCTION: Up-regulated in fibroblasts upon ionizing radiation, via a TP53-dependent pathway. Up-regulated by TP63 in primary keratinocytes, and down-regulated during keratinocyte differentiation. Up-regulated upon DNA alkylation. Up-regulated by amyloid beta-peptide and retinoic acid. Up-regulated by hypoxia, via a PI3K and HIF1A-dependent but TP53/TP63-independent mechanism (at protein level).
PTM: Phosphorylated by GSK3B; this promotes proteasomal degradation.
PTM: Polyubiquitinated by a DCX (DDB1-CUL4A-RBX1) E3 ubiquitin- protein ligase complex with BTRC as substrate-recognition component, leading to its proteasomal degradation.
SIMILARITY: Belongs to the DDIT4 family.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 550.74 RPKM in Ovary
Total median expression: 6600.76 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -82.00201-0.408 Picture PostScript Text
3' UTR -286.80848-0.338 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR012918 - RTP801-like

Pfam Domains:
PF07809 - RTP801 C-terminal region

Protein Data Bank (PDB) 3-D Structure
MuPIT help
3LQ9 - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on Q9NX09
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGDEnsembl   
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0071889 14-3-3 protein binding

Biological Process:
GO:0001666 response to hypoxia
GO:0001764 neuron migration
GO:0006915 apoptotic process
GO:0007420 brain development
GO:0008283 cell proliferation
GO:0009968 negative regulation of signal transduction
GO:0010801 negative regulation of peptidyl-threonine phosphorylation
GO:0030182 neuron differentiation
GO:0032007 negative regulation of TOR signaling
GO:0032984 macromolecular complex disassembly
GO:0033137 negative regulation of peptidyl-serine phosphorylation
GO:0042771 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
GO:0045820 negative regulation of glycolytic process
GO:0048011 neurotrophin TRK receptor signaling pathway
GO:0051607 defense response to virus
GO:0071549 cellular response to dexamethasone stimulus
GO:0072593 reactive oxygen species metabolic process
GO:1901216 positive regulation of neuron death
GO:1902532 negative regulation of intracellular signal transduction

Cellular Component:
GO:0005622 intracellular
GO:0005737 cytoplasm
GO:0005739 mitochondrion
GO:0005829 cytosol


-  Descriptions from all associated GenBank mRNAs
  LF208755 - JP 2014500723-A/16258: Polycomb-Associated Non-Coding RNAs.
HV708905 - JP 2012506450-A/3: Methods for treating eye disorders.
HW061126 - JP 2012529430-A/1: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
JA482131 - Sequence 114 from Patent WO2011072091.
JB251934 - Sequence 1 from Patent EP2440214.
JB614850 - Sequence 1 from Patent WO2013070821.
JE980423 - Sequence 114 from Patent EP2862929.
LP764833 - Sequence 1 from Patent EP3276004.
AL136668 - Homo sapiens mRNA; cDNA DKFZp564O2071 (from clone DKFZp564O2071).
JD186883 - Sequence 167907 from Patent EP1572962.
AK000507 - Homo sapiens cDNA FLJ20500 fis, clone KAT09159.
BC007714 - Homo sapiens DNA-damage-inducible transcript 4, mRNA (cDNA clone MGC:12610 IMAGE:4302878), complete cds.
AF335324 - Homo sapiens RTP801 mRNA, complete cds.
BC015236 - Homo sapiens DNA-damage-inducible transcript 4, mRNA (cDNA clone MGC:17872 IMAGE:3906374), complete cds.
JD409340 - Sequence 390364 from Patent EP1572962.
AY090097 - Homo sapiens REDD-1 (REDD-1) mRNA, complete cds.
BC000708 - Homo sapiens DNA-damage-inducible transcript 4, mRNA (cDNA clone MGC:1033 IMAGE:3507244), complete cds.
LF322514 - JP 2014500723-A/130017: Polycomb-Associated Non-Coding RNAs.
JD369772 - Sequence 350796 from Patent EP1572962.
JD401239 - Sequence 382263 from Patent EP1572962.
JD542265 - Sequence 523289 from Patent EP1572962.
AM392607 - Synthetic construct Homo sapiens clone IMAGE:100001897 for hypothetical protein (DDIT4 gene).
DQ890984 - Synthetic construct clone IMAGE:100003614; FLH168246.01X; RZPDo839E0292D DNA-damage-inducible transcript 4 (DDIT4) gene, encodes complete protein.
DQ894159 - Synthetic construct Homo sapiens clone IMAGE:100008619; FLH168242.01L; RZPDo839E0291D DNA-damage-inducible transcript 4 (DDIT4) gene, encodes complete protein.
AB587474 - Synthetic construct DNA, clone: pF1KB8579, Homo sapiens DDIT4 gene for DNA-damage-inducible transcript 4, without stop codon, in Flexi system.
KJ894039 - Synthetic construct Homo sapiens clone ccsbBroadEn_03433 DDIT4 gene, encodes complete protein.
LF322513 - JP 2014500723-A/130016: Polycomb-Associated Non-Coding RNAs.
DL257512 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270160 - Therapeutic Uses of Inhibitors of RTP801.
JA700132 - Sequence 277 from Patent EP2402443.
DL257511 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270159 - Therapeutic Uses of Inhibitors of RTP801.
JA700131 - Sequence 276 from Patent EP2402443.
DL257508 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270156 - Therapeutic Uses of Inhibitors of RTP801.
JA700128 - Sequence 273 from Patent EP2402443.
DL257504 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270152 - Therapeutic Uses of Inhibitors of RTP801.
JA700124 - Sequence 269 from Patent EP2402443.
DL257505 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270153 - Therapeutic Uses of Inhibitors of RTP801.
JA700125 - Sequence 270 from Patent EP2402443.
DL257488 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270136 - Therapeutic Uses of Inhibitors of RTP801.
JA700108 - Sequence 253 from Patent EP2402443.
LF322512 - JP 2014500723-A/130015: Polycomb-Associated Non-Coding RNAs.
JD540231 - Sequence 521255 from Patent EP1572962.
DL257489 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270137 - Therapeutic Uses of Inhibitors of RTP801.
JA700109 - Sequence 254 from Patent EP2402443.
DL257482 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270130 - Therapeutic Uses of Inhibitors of RTP801.
JA700102 - Sequence 247 from Patent EP2402443.
JD291915 - Sequence 272939 from Patent EP1572962.
JD294530 - Sequence 275554 from Patent EP1572962.
JD278668 - Sequence 259692 from Patent EP1572962.
DL257494 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270142 - Therapeutic Uses of Inhibitors of RTP801.
JA700114 - Sequence 259 from Patent EP2402443.
JD390426 - Sequence 371450 from Patent EP1572962.
JD045232 - Sequence 26256 from Patent EP1572962.
DL257499 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270147 - Therapeutic Uses of Inhibitors of RTP801.
JA700119 - Sequence 264 from Patent EP2402443.
DL257484 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270132 - Therapeutic Uses of Inhibitors of RTP801.
JA700104 - Sequence 249 from Patent EP2402443.
DL257502 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270150 - Therapeutic Uses of Inhibitors of RTP801.
JA700122 - Sequence 267 from Patent EP2402443.
DL257498 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270146 - Therapeutic Uses of Inhibitors of RTP801.
JA700118 - Sequence 263 from Patent EP2402443.
JD567102 - Sequence 548126 from Patent EP1572962.
JD278500 - Sequence 259524 from Patent EP1572962.
JD518920 - Sequence 499944 from Patent EP1572962.
JD124735 - Sequence 105759 from Patent EP1572962.
JD105756 - Sequence 86780 from Patent EP1572962.
DL257495 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270143 - Therapeutic Uses of Inhibitors of RTP801.
JA700115 - Sequence 260 from Patent EP2402443.
JD281041 - Sequence 262065 from Patent EP1572962.
DL257487 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270135 - Therapeutic Uses of Inhibitors of RTP801.
JA700107 - Sequence 252 from Patent EP2402443.
DL257485 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270133 - Therapeutic Uses of Inhibitors of RTP801.
JA700105 - Sequence 250 from Patent EP2402443.
LF322511 - JP 2014500723-A/130014: Polycomb-Associated Non-Coding RNAs.
JD177298 - Sequence 158322 from Patent EP1572962.
DL257501 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270149 - Therapeutic Uses of Inhibitors of RTP801.
JA700121 - Sequence 266 from Patent EP2402443.
DL257503 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270151 - Therapeutic Uses of Inhibitors of RTP801.
JA700123 - Sequence 268 from Patent EP2402443.
DL257500 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270148 - Therapeutic Uses of Inhibitors of RTP801.
JA700120 - Sequence 265 from Patent EP2402443.
LF322510 - JP 2014500723-A/130013: Polycomb-Associated Non-Coding RNAs.
JD186498 - Sequence 167522 from Patent EP1572962.
JD444552 - Sequence 425576 from Patent EP1572962.
JD484152 - Sequence 465176 from Patent EP1572962.
JD479444 - Sequence 460468 from Patent EP1572962.
JD544381 - Sequence 525405 from Patent EP1572962.
DL257483 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270131 - Therapeutic Uses of Inhibitors of RTP801.
JA700103 - Sequence 248 from Patent EP2402443.
DL257529 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270177 - Therapeutic Uses of Inhibitors of RTP801.
JA700149 - Sequence 294 from Patent EP2402443.
DL257530 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270178 - Therapeutic Uses of Inhibitors of RTP801.
JA700150 - Sequence 295 from Patent EP2402443.
DL257519 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270167 - Therapeutic Uses of Inhibitors of RTP801.
JA700139 - Sequence 284 from Patent EP2402443.
DL257497 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270145 - Therapeutic Uses of Inhibitors of RTP801.
JA700117 - Sequence 262 from Patent EP2402443.
DL257523 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270171 - Therapeutic Uses of Inhibitors of RTP801.
JA700143 - Sequence 288 from Patent EP2402443.
DL257517 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270165 - Therapeutic Uses of Inhibitors of RTP801.
JA700137 - Sequence 282 from Patent EP2402443.
DL257516 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270164 - Therapeutic Uses of Inhibitors of RTP801.
JA700136 - Sequence 281 from Patent EP2402443.
DL257522 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270170 - Therapeutic Uses of Inhibitors of RTP801.
JA700142 - Sequence 287 from Patent EP2402443.
LF322509 - JP 2014500723-A/130012: Polycomb-Associated Non-Coding RNAs.
DL257520 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270168 - Therapeutic Uses of Inhibitors of RTP801.
JA700140 - Sequence 285 from Patent EP2402443.
DL257515 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270163 - Therapeutic Uses of Inhibitors of RTP801.
JA700135 - Sequence 280 from Patent EP2402443.
DL257518 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270166 - Therapeutic Uses of Inhibitors of RTP801.
JA700138 - Sequence 283 from Patent EP2402443.
DL257521 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270169 - Therapeutic Uses of Inhibitors of RTP801.
JA700141 - Sequence 286 from Patent EP2402443.
DL257514 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270162 - Therapeutic Uses of Inhibitors of RTP801.
JA700134 - Sequence 279 from Patent EP2402443.
DL257509 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270157 - Therapeutic Uses of Inhibitors of RTP801.
JA700129 - Sequence 274 from Patent EP2402443.
DL257510 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270158 - Therapeutic Uses of Inhibitors of RTP801.
JA700130 - Sequence 275 from Patent EP2402443.
DL257507 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270155 - Therapeutic Uses of Inhibitors of RTP801.
JA700127 - Sequence 272 from Patent EP2402443.
DL257506 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270154 - Therapeutic Uses of Inhibitors of RTP801.
JA700126 - Sequence 271 from Patent EP2402443.
DL257491 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
DL257513 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270139 - Therapeutic Uses of Inhibitors of RTP801.
FU270161 - Therapeutic Uses of Inhibitors of RTP801.
JA700111 - Sequence 256 from Patent EP2402443.
JA700133 - Sequence 278 from Patent EP2402443.
DL257524 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270172 - Therapeutic Uses of Inhibitors of RTP801.
JA700144 - Sequence 289 from Patent EP2402443.
DL257527 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270175 - Therapeutic Uses of Inhibitors of RTP801.
JA700147 - Sequence 292 from Patent EP2402443.
DL257525 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270173 - Therapeutic Uses of Inhibitors of RTP801.
JA700145 - Sequence 290 from Patent EP2402443.
DL257528 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270176 - Therapeutic Uses of Inhibitors of RTP801.
JA700148 - Sequence 293 from Patent EP2402443.
DL257526 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270174 - Therapeutic Uses of Inhibitors of RTP801.
JA700146 - Sequence 291 from Patent EP2402443.
DL257492 - THERAPEUTIC USES OF INHIBITORS OF RTP801.
FU270140 - Therapeutic Uses of Inhibitors of RTP801.
JA700112 - Sequence 257 from Patent EP2402443.
LQ946190 - Sequence 1 from Patent WO2014043289.
MA558091 - JP 2018138019-A/130017: Polycomb-Associated Non-Coding RNAs.
MA558090 - JP 2018138019-A/130016: Polycomb-Associated Non-Coding RNAs.
MA558089 - JP 2018138019-A/130015: Polycomb-Associated Non-Coding RNAs.
MA558088 - JP 2018138019-A/130014: Polycomb-Associated Non-Coding RNAs.
MA558087 - JP 2018138019-A/130013: Polycomb-Associated Non-Coding RNAs.
MA558086 - JP 2018138019-A/130012: Polycomb-Associated Non-Coding RNAs.
MA444332 - JP 2018138019-A/16258: Polycomb-Associated Non-Coding RNAs.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q9NX09 (Reactome details) participates in the following event(s):

R-HSA-5632738 DDIT4 binds 14-3-3 dimer
R-HSA-5628897 TP53 Regulates Metabolic Genes
R-HSA-3700989 Transcriptional Regulation by TP53
R-HSA-212436 Generic Transcription Pathway
R-HSA-73857 RNA Polymerase II Transcription
R-HSA-74160 Gene expression (Transcription)

-  Other Names for This Gene
  Alternate Gene Symbols: DDIT4_HUMAN, ENST00000307365.1, ENST00000307365.2, NM_019058, Q9H0S3, Q9NX09, REDD1, RTP801, uc317obb.1
UCSC ID: ENST00000307365.3
RefSeq Accession: NM_019058.4
Protein: Q9NX09 (aka DDIT4_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.